Veterans' Support Amendment Regulations (No 4) 2021

2021/181

Coat of Arms of New Zealand

Veterans’ Support Amendment Regulations (No 4) 2021

Patsy Reddy, Governor-General

Order in Council

At Wellington this 5th day of July 2021

Present:
Her Excellency the Governor-General in Council

These regulations are made under sections 23(3) and 265 of the Veterans’ Support Act 2014

(a)

on the advice and with the consent of the Executive Council; and

(b)

on the recommendation of the Minister for Veterans made in accordance with section 23 of that Act.

Regulations

1 Title

These regulations are the Veterans’ Support Amendment Regulations (No 4) 2021.

2 Commencement

These regulations come into force on 5 August 2021.

3 Principal regulations

These regulations amend the Veterans’ Support Regulations 2014.

4 Schedule 1 amended

Amend Schedule 1 as set out in Schedule 1 of these regulations.

5 Schedule 2A amended

Amend Schedule 2A as set out in Schedule 2 of these regulations.

Schedule 1 Amendments to Schedule 1

cl 4

Revoke the items relating to acute lymphoblastic leukaemia and adenocarcinoma of the kidney.

Insert in their appropriate alphabetical order:

acute lymphoblastic leukaemia/lymphoblastic lymphoma33/202134/2021
malignant neoplasm of the kidney41/202142/2021
posterior tibialis tendinopathy45/202146/2021

In the item relating to ankylosing spondylitis,—

(a)

replace “3/2013” with “39/2021”; and

(b)

replace “4/2013” with “40/2021”.

In the item relating to asthma,—

(a)

replace “60/2012” with “31/2021”; and

(b)

replace “61/2012” with “32/2021”.

In the item relating to deep vein thrombosis,—

(a)

replace “54/2012” with “35/2021”; and

(b)

replace “55/2012” with “36/2021”.

In the item relating to pulmonary thromboembolism,—

(a)

replace “56/2012” with “37/2021”; and

(b)

replace “57/2012” with “38/2021”.

In the item relating to seborrhoeic dermatitis,—

(a)

replace “13/2013” with “43/2021”; and

(b)

replace “14/2013” with “44/2021”.

Schedule 2 Amendments to Schedule 2A

cl 5

Revoke the items relating to:

(a)

acute lymphoblastic leukaemia:

(b)

adenocarcinoma of the kidney:

(c)

alzheimer-type dementia:

(d)

aortic aneurysm:

(e)

carotid arterial disease:

(f)

Cushing’s syndrome:

(g)

Cut, stab, abrasion and laceration:

(h)

dengue fever:

(i)

extrinsic allergic alveolitis:

(j)

familial hypertrophic cardiomyopathy:

(k)

haemochromatosis:

(l)

human immunodeficiency virus:

(m)

human T-cell lymphotropic virus type 1:

(n)

immune thrombocytopaenic purpura:

(o)

Kaposi’s sarcoma:

(p)

malignant neoplasm of the testis and paratesticular tissue:

(q)

meliodosis:

(r)

microscopic polyantiitis:

(s)

myelodysplastic disorder:

(t)

non-Hodgkin’s lymphoma:

(u)

osteogensis imperfecta:

(v)

Parkinson’s disease and parkinsonism:

(w)

peritonal adhesions:

(x)

physical injury due to munitions discharge:

(y)

poisoning and toxic reaction from plants and fungi:

(z)

post-traumatic stress disorder:

(za)

rapidly progressing crescentic glomerulonephritis:

(zb)

schistomosomiasis:

(zc)

thromboagniitis obliterans.

Insert in their appropriate alphabetical order:

acute lymphoblastic leukaemia/lymphoblastic lymphoma
Alzheimer disease
aortic aneurysm and aortic wall disorders
carotid artery disease
Cushing syndrome
cut, stab, abrasion and laceration
dengue virus infection
explosive blast injury
gunshot injury
hereditary haemochromatosis
human immunodeficiency virus infection
human T-cell lymphotropic virus type-1 infection
hypersensitivity pneumonitis
immune thrombocytopaenia
Kaposi sarcoma
malignant neoplasm of the kidney
malignant neoplasm of the testis and paratesticular tissues
melioidosis
microscopic polyangiitis
myelodysplastic syndrome
neurocognitive disorder with Lewy bodies
non-Hodgkin lymphoma
osteogenesis imperfecta
Parkinson’s disease and secondary parkinsonism
peritoneal adhesions
poisoning from plants or fungi
posttraumatic stress disorder
rapidly progressive crescentic glomerulonephritis
schistosomiasis
thromboangiitis obliterans

Michael Webster,
Clerk of the Executive Council.

Explanatory note

This note is not part of the regulations, but is intended to indicate their general effect.

These regulations, which come into force on 5 August 2021, amend the Veterans’ Support Regulations 2014 (the principal regulations).

Regulation 4 and Schedule 1 amend Schedule 1 of the principal regulations, which lists the Australian statements of principles (the statements) that apply to specified medical conditions for the purposes of the Veterans’ Support Act 2014 (the Act). The amendments—

  • replace the names of 2 conditions in order to to reflect the statements (note that the condition adenocarcinoma of the kidney is now called malignant neoplasm of the kidney):

  • insert a new condition, posterior tibialis tendinopathy, to which the statements apply:

  • replace references to the statements with updated references.

Regulation 5 and Schedule 2 amend Schedule 2A of the principal regulations, which lists accepted late-onset conditions for the purposes of the definition of accepted late-onset condition in section 7 of the Act. The amendments replace the names of 29 conditions in order to reflect the statements. In most cases, it is clear which new name corresponds to the previous name for the relevant condition. For clarity, it is worth noting that—

  • the condition alzheimer-type dementia is now 2 new conditions, Alzheimer disease and neurocognitive disorder with Lewy bodies:

  • the condition physical injury due to munitions discharge is now 2 new conditions, explosive blast injury and gunshot injury:

  • the condition adenocarcinoma of the kidney is now called malignant neoplasm of the kidney:

  • the conditon extrinsic allergic alveolitis is now called hypersensitivity pneumonitis.

The reference to the condition familial hypertrophic cardiomyopathy has been revoked, as, under the statements, that condition is now part of the condition cardiomyopathy, which is already listed in Schedule 2A.

Issued under the authority of the Legislation Act 2012.

Date of notification in Gazette: 8 July 2021.

These regulations are administered by the New Zealand Defence Force.